Venous thromboembolism prophylaxis in critically ill patients

Seminars in Thrombosis and Hemostasis

Volumn 41, Issue 1, 2015, Pages 68-74

  Boonyawat, Kochawan ^a,b   Crowther, Mark A ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

critical illness; prevention; venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO;

ANTICOAGULATION; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING DISORDER; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DRUG CLEARANCE; DRUG EFFICACY; EVIDENCE BASED PRACTICE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; KIDNEY FUNCTION; LUNG EMBOLISM; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); PATIENT COMPLIANCE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SYSTEMATIC REVIEW (TOPIC); THROMBOSIS PREVENTION; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

CRITICAL ILLNESS; HUMANS; META-ANALYSIS AS TOPIC; VENOUS THROMBOEMBOLISM;

EID: 84928473250     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0034-1398386     Document Type: Article

References (52)

1. Moser K. M., LeMoine J. R., Nachtwey F. J., Spragg R. G. Deep venous thrombosis and pulmonary embolism. Frequency in a respiratory intensive care unit. JAMA: 1981; 246 13 1422 1424
2. Geerts W., Cook D., Selby R., Etchells E. Venous thromboembolism and its prevention in critical care. J Crit Care: 2002; 17 2 95 104
3. Wilasrusmee C., Kiranantawat K., Horsirimanont S., et al. Deep venous thrombosis in surgical intensive care unit: prevalence and risk factors. Asian J Surg: 2009; 32 2 85 88
4. Angral R., Islam M. S., Kundan S. Incidence of deep vein thrombosis and justification of chemoprophylaxis in Indian patients: a prospective study. Bangladesh Med Res Counc Bull: 2012; 38 2 67 71
5. Cade J. F. High risk of the critically ill for venous thromboembolism. Crit Care Med: 1982; 10 7 448 450
6. Ribic C., Lim W., Cook D., Crowther M. Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review. J Crit Care: 2009; 24 2 197 205
7. Khouli H., Shapiro J., Pham V. P., et al. Efficacy of deep venous thrombosis prophylaxis in the medical intensive care unit. J Intensive Care Med: 2006; 21 6 352 358
8. Cook D., Crowther M., Meade M., et al. Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med: 2005; 33 7 1565 1571
9. Ho K. M., Chavan S., Pilcher D. Omission of early thromboprophylaxis and mortality in critically ill patients: a multicenter registry study. Chest: 2011; 140 6 1436 1446
10. Lilly C. M., Liu X., Badawi O., Franey C. S., Zuckerman I. H. Thrombosis prophylaxis and mortality risk among critically ill adults. Chest: 2014; 146 1 51 57
11. Kapoor M., Kupfer Y. Y., Tessler S. Subcutaneous heparin prophylaxis significantly reduces the incidence of venous thromboembolic events in the critically ill. Crit Care Med: 1999; 27 12 A69
12. Fraisse F., Holzapfel L., Couland J. M., et al. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. Am J Respir Crit Care Med: 2000; 161 4, Pt 1 1109 1114
13. Shorr A. F., Williams M. D. Venous thromboembolism in critically ill patients. Observations from a randomized trial in sepsis. Thromb Haemost: 2009; 101 1 139 144
14. Alhazzani W., Lim W., Jaeschke R. Z., Murad M. H., Cade J., Cook D. J. Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med: 2013; 41 9 2088 2098
15. Kahn S. R., Lim W., Dunn A. S., et al. American College of Chest Physicians. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest: 2012; 141 (2, Suppl): e195S e226S
16. Plott R. T., Wagner R. F. Jr, Tyring S. K. Iatrogenic contamination of multidose vials in simulated use. A reassessment of current patient injection technique. Arch Dermatol: 1990; 126 11 1441 1444
17. Bruguera M., Saiz J. C., Franco S., et al. Outbreak of nosocomial hepatitis C virus infection resolved by genetic analysis of HCV RNA. J Clin Microbiol: 2002; 40 11 4363 4366
18. De A., Roy P., Garg V. K., Pandey N. K. Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery. Blood Coagul Fibrinolysis: 2010; 21 1 57 61
19. Cook D., Meade M., Guyatt G., et al. PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med: 2011; 364 14 1305 1314
20. Goldhaber S. Z., Kett D. H., Cusumano C. J., et al. Low molecular weight heparin versus minidose unfractionated heparin for prophylaxis against venous thromboembolism in medical intensive care unit patients: A randomized controlled trial. J Am Coll Cardiol: 2000; 35 (Suppl): 325A
21. Connolly S. J., Ezekowitz M. D., Yusuf S., et al. RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med: 2009; 361 12 1139 1151
22. Patel M. R., Mahaffey K. W., Garg J., et al. ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med: 2011; 365 10 883 891
23. Granger C. B., Alexander J. H., McMurray J. J., et al. ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med: 2011; 365 11 981 992
24. Giugliano R. P., Ruff C. T., Braunwald E., et al. ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med: 2013; 369 22 2093 2104
25. Goldhaber S. Z., Leizorovicz A., Kakkar A. K., et al. ADOPT Trial Investigators. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med: 2011; 365 23 2167 2177
26. Cohen A. T., Spiro T. E., Büller H. R., et al. MAGELLAN Steering Committee. Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med: 2013; 368 20 1945 1946
27. Decousus H., Tapson V. F., Bergmann J. F., et al. IMPROVE Investigators. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest: 2011; 139 1 69 79
28. Agnelli G., Piovella F., Buoncristiani P., et al. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med: 1998; 339 2 80 85
29. Limpus A., Chaboyer W., McDonald E., Thalib L. Mechanical thromboprophylaxis in critically ill patients: a systematic review and meta-analysis. Am J Crit Care: 2006; 15 4 402 410, discussion, 411-412
30. Zhang C., Zeng W., Zhou H., et al. [The efficacy of intermittent pneumatic compression in the prevention of venous thromboembolism in medical critically ill patients]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue: 2011; 23 9 563 565
31. Arabi Y. M., Khedr M., Dara S. I., et al. Use of intermittent pneumatic compression and not graduated compression stockings is associated with lower incident VTE in critically ill patients: a multiple propensity scores adjusted analysis. Chest: 2013; 144 1 152 159
32. Vignon P., Dequin P. F., Renault A., et al. Clinical Research in Intensive Care and Sepsis Group (CRICS Group). Intermittent pneumatic compression to prevent venous thromboembolism in patients with high risk of bleeding hospitalized in intensive care units: the CIREA1 randomized trial. Intensive Care Med: 2013; 39 5 872 880
33. Decousus H., Leizorovicz A., Parent F., et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med: 1998; 338 7 409 415
34. Group P. S.; PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation: 2005; 112 3 416 422
35. Sarosiek S., Crowther M., Sloan J. M. Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center. JAMA Intern Med: 2013; 173 7 513 517
36. Keane M. G., Ingenito E. P., Goldhaber S. Z. Utilization of venous thromboembolism prophylaxis in the medical intensive care unit. Chest: 1994; 106 1 13 14
37. Ryskamp R. P., Trottier S. J. Utilization of venous thromboembolism prophylaxis in a medical-surgical ICU. Chest: 1998; 113 1 162 164
38. Cook D., Attia J., Weaver B., McDonald E., Meade M., Crowther M. Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients. J Crit Care: 2000; 15 4 127 132
39. Muscedere J. G., Heyland D. K., Cook D. Venous thromboembolism in critical illness in a community intensive care unit. J Crit Care: 2007; 22 4 285 289
40. Robertson M. S., Nichol A. D., Higgins A. M., et al. VTE Point Prevalence Investigators for the Australian and New Zealand Intensive Care Research Centre; Australian and New Zealand Intensive Care Society Clinical Trials Group. Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units. Crit Care Resusc: 2010; 12 1 9 15
41. Ge J., Li Y., Jin X., Zhou J. Venous thromboembolism risk assessment and thromboprophylaxis among hospitalized acute medical patients in China-the RAMP study. Thromb Res: 2010; 126 4 270 275
42. Al-Otair H. A., Khurshid S. M., Alzeer A. H. Venous thromboembolism in a medical intensive care unit. The effect of implementing clinical practice guidelines. Saudi Med J: 2012; 33 1 55 60
43. Parikh K. C., Oh D., Sittipunt C., Kalim H., Ullah S., Aggarwal S. K.; VOICE Asia Investigators. Venous thromboembolism prophylaxis in medical ICU patients in Asia (VOICE Asia): a multicenter, observational, cross-sectional study. Thromb Res: 2012; 129 4 e152 e158
44. Yamamoto T., Nakamura M., Kuroiwa M., Tanaka K. Current prevention practice for venous thromboembolism in Japanese intensive care units. J Anesth: 2013; 27 6 931 934
45. García-Olivares P., Guerrero J. E., Galdos P., Carriedo D., Murillo F., Rivera A. PROF-ETEV study: prophylaxis of venous thromboembolic disease in critical care units in Spain. Intensive Care Med: 2014; 40 11 1698 1708
46. Boddi M., Barbani F., Abbate R., et al. Reduction in deep vein thrombosis incidence in intensive care after a clinician education program. J Thromb Haemost: 2010; 8 1 121 128
47. McMullin J., Cook D., Griffith L., et al. Minimizing errors of omission: behavioural reenforcement of heparin to avert venous emboli: the BEHAVE study. Crit Care Med: 2006; 34 3 694 699
48. Teixeira P. G., Inaba K., Dubose J., et al. Measurable outcomes of quality improvement using a daily quality rounds checklist: two-year prospective analysis of sustainability in a surgical intensive care unit. J Trauma Acute Care Surg: 2013; 75 4 717 721
49. DuBose J. J., Inaba K., Shiflett A., et al. Measurable outcomes of quality improvement in the trauma intensive care unit: the impact of a daily quality rounding checklist. J Trauma: 2008; 64 1 22 27, discussion 27-29
50. Dubose J., Teixeira P. G., Inaba K., et al. Measurable outcomes of quality improvement using a daily quality rounds checklist: one-year analysis in a trauma intensive care unit with sustained ventilator-associated pneumonia reduction. J Trauma: 2010; 69 4 855 860
51. Kucher N., Koo S., Quiroz R., et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med: 2005; 352 10 969 977
52. Mitchell J. D., Collen J. F., Petteys S., Holley A. B. A simple reminder system improves venous thromboembolism prophylaxis rates and reduces thrombotic events for hospitalized patients1. J Thromb Haemost: 2012; 10 2 236 243